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Abstract
The absence of L-ascorbic acid (L-AA, or AA) syn-
thesis in scurvy-prone organisms, including hu-
mans, other primates, guinea pigs, and flying
mammals, was traced to the lack of L-gulonolactone
oxidase (GULO) activity. GULO is a microsomal
enzyme that catalyzes the terminal step in the bio-
synthesis of L-AA. Clinical cases of scurvy were
described in a family of Danish pigs. This trait is
controlled by a single autosomal recessive allele
designated od (osteogenic disorder). Here we dem-
onstrate that the absence of GULO activity and the
associated vitamin C deficiency in od/od pigs is due
to the occurrence of a 4.2-kbp deletion in the GULO
gene. This deletion includes 77 bp of exon VIII, 398
bp of intron 7 and 3.7 kbp of intron 8, which leads to
a frame shift. The mutant protein is truncated to 356
amino acids, but only the first 236 amino acids are
identical to the wild-type GULO protein. In addi-
tion, the od allele seems to be less expressed in de-
ficient and heterozygous pigs compared with the
normal allele in heterozygous and wild-type animals
as determined by ribonuclease protection assay. We
also developed a DNA-based test for the diagnosis of
the deficient allele. However, we failed to identify
the mutated allele in other pig populations.
Vitamin C (the generic term for L-ascorbic acid, L-
AA, or AA) acts as a metabolic antioxidant, detoxi-
fying numerous peroxide metabolites and thereby
protecting cell membranes and other intracellular
components and processes that are sensitive to oxi-
dation (Buettner and Jurkiewicz 1996). L-AA also
acts as a cofactor in the hydroxylation of proline and
lysine in the synthesis of collagen (Ronchetti et al.
1996; Weiser et al. 1992), a major component of the
extracellular matrix of connective tissues, blood
vessels, bone matrix, and scar tissue in wound re-
pair. In addition, L-AA stimulates various cellular
and humoral immune functions (Schwager and
Schulze 1997, 1998a, 1998b).
The terminal step in the biosynthesis of L-AA in
mammals is dependent on L-gulonolactone oxidase (L-
gulono-gamma-lactone oxidase, GULO, EC 1.1.3.8).
GULO is a membrane-bound flavoenzyme present in
the microsomal fraction of liver cell homogenates.
The GULO enzyme includes an FAD molecule that is
covalently bound to the apoprotein through an 8a-
[N(l)-histidyl]-riboflavin linkage (Kenney et al. 1976;
Kiuchi et al. 1982). The enzyme converts L-gulono-
lactone to L-keto-guIono-gamma-Iactone, whereby
L-AA is produced through isomerization (Burns and
Mosbach 1956; Chatterjee et al. 1958).
Chatterjee (1973) reported that vertebrates which
are phylogenetically higher than fish possess the
GULO enzyme, and these animals can, therefore,
synthesize L-AA from D-glucose. However, this en-
zyme is absent in humans, other primates (Birney
et al. 1976), guinea pigs and bats (Burns 1957;
Chatterjee 1973; Chatterjee et al. 1975). Conse-
quently, these species require a dietary intake of
vitamin C to prevent scurvy.
Interestingly, it appears that the localization of
GULO expression shifted from the kidney to the
liver during evolution; mammals and highly evolved
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birds express GULO in the liver, whereas primitive
birds, reptiles, and amphibia express it in the kidney.
Normally, pigs produce sufficient levels of L-AA
to meet their requirements. However, a number of
years ago, a mutant family of Danish pigs that lacks
the ability to produce L-AA was discovered, and
clinical cases of scurvy were described in swine for
the first time (Jensen et al. 1983). Clinical signs of
vitamin C deficiency in pigs include unwillingness
to move, swelling around joints, signs of pain upon
touching, multiple fractures, and hemorrhagic ten-
dencies. This trait is controlled by a single auto-
somal recessive allele designated od (osteogenic
disorder). Unlike od/od pigs, which are vitamin C
deficient, OD/OD, or wild-type pigs, and heterozy-
gous OD/od pigs do not depend on dietary sources of
L-AA to maintain vital functions.
Swine represent a particularly attractive model
for studies on vitamin C deficiency. Humans and
pigs seem to be physiologically and from point of
view of the nutritional requirements very similar.
The objective of the present study was to charac-
terize the molecular basis of the vitamin C defi-
ciency in od/od pigs.
Material and methods
Pigs and sampling. Semen from a deficient od/od
Landrace boar was transferred to five wild-type Large
White sows (hereafter referred to as wild-type OD/
OD). The F1 offspring were crossed (F1 · F1) and
maintained for further breeding. The phenotype of
the F2 experimental pigs was determined by meas-
uring the plasma AA as described (Hasan et al. 1999).
Eight pigs in each group (OD/OD, OD/od, and od/
od) were used in this study. From weaning until the
pigs reached a body weight (BW) of 25 kg, the pigs
were group penned and fed a conventional starter
diet ad libitum. The vitamin C-deficient pigs re-
ceived a daily supplement of 30 mg crystalline AA
per kg BW from weaning until slaughter or until the
start of the feeding trial.
When pigs reached a BW of 45 kg, blood samples
were collected for extraction of genomic DNA. For
determination of plasma AA, blood samples were
collected in siliconized glass tubes containing sodi-
um heparin (15 U/mL), immediately placed on ice,
and centrifuged (1600 g for 15 min at 4C) within 45
min. The collected plasma was immediately stabi-
lized with 50% (wt/vol) metaphosphoric acid at a 9:1
ratio and stored at )20C. All pigs were slaughtered
when they reached a BW of 100 kg. Livers were ob-
tained within 20 min post-mortem, frozen in liquid
nitrogen, and stored at )80C.
Total L-AA determination. The amount of total
L-AA in plasma or in the solubilized microsomes was
measured by the dinitrophenylhydrazine method
(Roe and Kuether 1943) with a modification, in
which the oxidation of AA was accomplished with
2,6-dichlorophenolindophenol (Dabrowski and Hin-
terleitner 1989). The reaction ran in the presence of
stannous chloride dehydrate (0.4%). Maximal ab-
sorption of the derivative bis-2,4-dinitrophenylhydr-
azine was measured at 530 nm. The total AA
concentration was estimated by using L-AA as a
standard (Sigma-Aldrich Chemie).
GULO activity assay. Porcine liver samples
(0.5 g) were homogenized in 4 mL of 0.25 M sucrose
and centrifuged at 14,000 g for 25 min at 4C.
Supernatants were centrifuged at 100,000 g for 60
min at 4C. The microsomes (pellets) were solubi-
lized in 2 mL of 20 mM Tris acetate (pH 8.0) con-
taining 1 mM EDTA, 10 mM KCl, and 0.3% sodium
deoxycholate, and were centrifuged at 13,000 g for
30 min at 4C. The GULO assay reaction mixture
contained 50 mM potassium phosphate buffer (pH
7.0), 50 mM sodium citrate, and 400 lL of solubi-
lized microsomes (about 2 mg proteins). The enzy-
matic reaction was initiated by the addition of 10
mM L-gulonolactone (Fluka Chemie) as a substrate
and incubated in aerobic conditions at 37C with
vigorous shaking for 1 h. Reactions were stopped by
the addition of metaphosphoric acid to a final
concentration of 5%. After centrifugation at 15,000
g for 15 min at 4C, the total amount of L-AA (re-
duced and oxidized forms) in the supernatants was
determined, as described above. The absorbance of
the control (addition of buffer instead of substrate)
was deducted, correcting for interfering substances
and initial vitamin C content of the sample. GULO
activity was expressed as lg of AA synthesized in
vitro per mg of microsomal protein per h at 37C.
Each enzymatic assay contained a control tube
without substrate. Rat GULO activity was also
measured, as a positive control.
Primers. Primers derived from the rat or guinea
pig Gulo gene were used to amplify its porcine
counterpart from genomic DNA and cDNA. Se-
quences of these primers are shown in Table 1.
DNA isolation. Genomic DNA was isolated
from whole blood by using either a rapid procedure
(Vo¨geli et al. 1994) or the method of Sambrook et al.
(1989). Cosmid DNA was isolated with Qiagen tip
100 columns, according to the manufacturer’s rec-
ommended protocol.
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DNA sequencing. Sequencing was performed
with the Ready Reaction Dye Terminator kit (Ap-
plied Biosystems) and an ABI 373A DNA sequencer.
DNA sequences were analyzed with the GCG (Ge-
netics Computer Group) software package (Devereux
et al. 1984).
PCR. Standard PCR was carried out in a reaction
volume of 25 lL containing 200 ng of porcine ge-
nomic DNA with 2.5 U of Taq DNA polymerase as
described by the manufacturer (Amersham Pharma-
cia Biotech). The PCR profile was 95C for 5 min,
followed by 35 cycles of 95C for 30 s, 62–66C for
30 s, and 72C for 90 s, and a final extension at 72C
for 7 min. A long-range interexon PCR was carried
out in a reaction volume of 50 lL containing
200–250 ng of porcine genomic DNA (or 30 ng cos-
mid DNA) by using Expand High Fidelity polym-
erase (Roche Diagnostics).
DNA-based test for vitamin C deficiency. A
two-plex PCR was performed with the following
primers: GLO7p0, nGLOi7p2, nGLOi8p3, and
dGLOi7p1. The PCR profile was 95C for 5 min,
followed by 35 cycles of 95C for 30 s, 62C for 30 s,
and 72C for 90 s, and a final extension at 72C for 7
min.
Isolation of GULO cDNA clones. A pig liver
cDNA library k-ZAP XR (Stratagene Europe) was
kindly provided by the Department of Pathology of
the University Hospital, Zu¨rich, Switzerland. Plaque
lifts were performed according to the manufacturer’s
instructions. Membranes with a total of 106-plaques
were hybridized to 158 bp-[a-32P]dATP-labeled
GULO PCR fragments by using the GLO9gp0 and
GLO10r3 primers (Table 1). Thirty-three positive
plaques were identified. A second screening was
performed under stringent conditions by using a
cDNA probe (exons III–VII) with the GLO3r0 and
GLO7pl primers. Two clones have been selected for
sequence analyses, and the clone containing the
largest insert was designated 13-1b2.
Total RNA isolation. Total RNA was obtained
by homogenizing frozen tissue in solution D
(Chomczynski and Sacchi 1987), followed by ultra-
centrifugation through a caesium chloride cushion
(Chirgwin et al. 1979).
Northern blot analysis. Total RNA (20 lg) was
separated by electrophoresis on a denaturing 1.25%
agarose gel containing 0.66 M formaldehyde, and
transferred overnight to a Duralon-UV nylon mem-
brane (Stratagene) by passive capillary transfer. Hy-
bridization was carried out overnight at 50C with a
158-bp [a-32P]dATP-labeled PCR fragment (exons
IX–X) of the putative GULO cDNA. Autoradiogra-
phy was performed with X-OMAT X-ray film (Sig-
ma-Aldrich Chemie). The membrane was stripped
and rehybridized with a 212-bp [a-32P]dATP-labeled
pig b-actin cDNA PCR-fragment (bp 376–587 of the
coding sequence; accession number U07786).
Ribonuclease protection assay. The ribonuc-
lease protection assay was carried out as described
previously (Neuenschwander et al. 1995). A 399-bp
[a-32P]UTP-labeled antisense riboprobe for GULO
was constructed from clone 13-1b2. In a two-step
cloning procedure, the 333-bp PstI/BglII cDNA
fragment (position 776–1108, accession number
AF440259, covering exons VI–IX) was ligated into
plasmid pBluescript II (Stratagene Europe). Following
linearization with BamHI, a 399-bp [a-32P]UTP-
Table 1. Sequences of GULO primers. The name, sequence, and position in the porcine GULO of the first nucleotide (5¢-
end) are indicated for each primer. Primers with lowercase letters p, r, or gp are derived from the pig, rat, or guinea pig
GULO gene, respectively; n or d designates the specificity to the wild-type or deficient allele, respectively. (F), forward
primer; (R), reverse primer. Position numbers indicate the relative position of the 5¢ end of the primers to the porcine
GULO start codon.
Primer name Primer sequence (5¢-3¢) Position
GLO3r0 (F) GATCCACATGGGCAAGATGAACC 198
GLO3p3 (R) CTTGAGGACCGCGGTTCATCTTG 231
GLO6p0 (F) CTGCAGTGTGCCCCAGTTCCACTTG 544
GLO7p0 (F) GGTTCCCACACAGCGAGAACGTCAG 659
GLO7p1 (R) CTGACGTTCTCGCTGTGTGGGAACC 683
GLO9gp0 (F) ACGTCCAGGACTGGGCCATCCC 914
GLO9p1 (R) GATCCAGCCCACGAGGCCTGGCACG 819
GLO10r3 (R) CCTCTGGAAGCAGGGGCTCAG 1071
nGLOi7p2 (F) CAGCTCTGGCCCTGAACTGATC intron 7 (3¢-end)
nGLOi8p3 (R) CTCCAACCATACATGGCAGATGC intron 8 (5¢-end)
dGLOi7p1 (R) CCGACTAGGAACATGAGGTTGAGG intron 7 (5¢-end)
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labeled antisense riboprobe was synthesized with T7
RNA polymerase. The pT7-18S control template
(Ambion) was used to synthesize a 109-bp [a-32P]
UTP-labeled 18S antisense riboprobe. Total RNA (20
lg) from liver was hybridized with GULO and 18S
antisense riboprobes at 45 C overnight, digested
with RNase A and T1, and subjected to electropho-
resis on a denaturing 8% polyacrylamide gel. The gel
was dried and exposed to a direct Imager (Packard).
Signals were quantified using the Instant Imager
analysis software version 2.05 (Canberra-Packard).
Detection of GULO mRNA by RT-PCR. The
reverse transcriptase (RT) reaction was performed
with 2.5 lg of total RNA, 4 lM of d(T)17VX (V = A, G,
or C; X = A, C, G, or T), or GLO10r3 reverse primer
and 15 U AMV reverse transcriptase (Promega) ac-
cording to the manufacturer’s instruction. A 276-bp
GULO cDNA fragment (exons VI–IX) was amplified
with GLO6p0 and GLO9p1 primers (Table 1). The
PCR profile included incubation at 95C for 5 min,
followed by 40 cycles of 95C for 30 s, 57C for 30 s,
and 72C for 90 s, and a final extension at 72C for
7 min.
Statistics. Intensities of protected bands in ri-
bonuclease protection assays are expressed as aver-
age ± SEM (standard error of the mean). After
subtraction of basal (background) values and correc-
tion for the RNA loading (18S), the intensity of the
protected bands from the od allele was normalized
according to the difference in UTP content between
wild-type and mutated GULO mRNA. For allele
differences, mean intensity of signals was evaluated
by analysis of variance by using the general linear
model procedure in the statistical software package
SYSTAT 9.01 (SPSS Inc. Chicago, IL). When the
F test was significant (P < 0.05), allele differences
were analyzed by Bonferroni t test.
Results
Plasma AA and GULO activity of wild-type (OD/
OD), heterozygous (OD/od), and deficient (od/od)
pigs. We measured total L-AA concentrations in
plasma of phenotypically normal and deficient ani-
mals one week after AA deprivation in the feed
(Fig. 1). The average plasma AA concentration was
significantly lower in heterozygous (OD/od) pigs
(4.06 ± 0.40 mg AA/L, n = 4) than in wild-type (OD/
OD) pigs (6.99 ± 0.28 mg AA/L, n = 8; P < 0.001)
although heterozygous animals did not exhibit any
symptoms of scurvy. As expected, plasma AA levels
were barely detectable in vitamin C-deficient od/od
pigs (0.23 ± 0.40 mg AA/L, n = 4; P < 0.001).
GULO activity was measured in the soluble
microsomal fraction of liver homogenates from rats,
wild-type and vitamin C-deficient pigs (Fig. 1).
GULO activity in the rat was 14.4 lg AA/h/mg
protein, which is similar to that reported in a pre-
vious study (Dabrowski and Hinterleitner 1989).
GULO activity levels closely paralleled plasma L-AA
levels. Very low GULO activity was detected in od/
od pigs (0.21 ± 0.86 lg AA/h/mg protein). GULO
activity was lower in heterozygous pigs, as compared
with wild-type pigs (7.32 ± 0.60 lg AA/h/mg protein
for OD/OD pigs and 4.86 ± 0.76 lg AA/h/mg protein
for OD/od pigs). However, this difference did not
achieve statistical significance (P = 0.107).
Organization of the porcine GULO gene. To
analyze the genomic organization of the GULO
gene, sequences derived from a full-length porcine
Fig. 1. Plasma AA and GULO activity in
wild-type (OD/OD), heterozygous (OD/
od) and vitamin C-deficient pigs (od/od).
Plasma AA concentration in pigs was
measured one week after AA deprivation
in the feed. Plasma AA concentration
decreased dramatically in the deficient
pigs. GULO activity in liver represents
the total AA in vitro synthesized during
1 h reaction per mg microsomal protein
at 37C. Only a negligible GULO activity
was detected in the deficient pigs. Data
are expressed as average ± SEM.
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GULO cDNA clone (13-1b2) were compared with
genomic sequences of PCR products and with pre-
viously isolated cosmid DNA clones (Hasan et al.
1999). The sequence of the clone 13-1b2 represents a
1320-bp potential ORF and is 86.7% identical at the
nucleotide level, and 92.3% identical at the amino
acid level, with the rat Gulo sequence (data not
shown; accession number AF440259). The GULO
gene of wild-type pigs is composed of 12 exons (I to
XII) and 11 introns, as determined by comparing
porcine genomic and cDNA GULO sequences. All
identified putative intron/exon boundaries of the
normal OD allele followed the GT/AG rule (Mount
1982), as shown in Table 2.
Exon VIII is deleted in the cDNA of od/od
pigs. We performed RT-PCR analysis to determine
whether mutations of the GULO cDNA were in-
volved in the pathogenesis of vitamin C deficiency in
pigs. Using an appropriate set of primers (GLO6p0
and GLO9p1; Table l), we identified two distinct PCR
products (276 bp and 199 bp) in the liver of wild-type
and affected pigs. Both products were detected in the
genetically characterized heterozygous pigs (Fig. 2A
and 2B). Sequence analysis of PCR products revealed
that this deleted region of 77 bp corresponds to the
homologous exon VIII of the Gulo cDNA sequence in
rat (Nishikimi et al. 1994). No other differences were
found in the entire cDNA. The sequence of the first
236 amino acids was identical between the wild-type
OD and the mutated od alleles of the putative mature
peptide (Fig. 2C). The deletion of exon VIII caused a
frameshift, which predicts a translation termination
at nucleotide position 1149, thereby resulting in a
truncated peptide of 356 amino acids.
On the basis of the known post-translational
modifications of the rat protein (Koshizaka et al.
1988), we predict a molecular weight of 50.2 kDa for
the wild-type and 38.4 kDa for the mutated mature
GULO peptide (www.expasy.ch/tools/pi_tool.html,
Expasy home page).
Intragenic deletion of the GULO gene causes
vitamin C-deficient pigs. In order to check whether
the truncation of the GULO cDNA in od/od pigs is
caused by abnormal splicing of exon VIII or by de-
letion of exon VIII in the GULO gene, we amplified
the genomic DNA between exons VII and IX for the
GULO gene from each genotype. Long-range PCR
analysis showed a size difference of 4.2 kilobase pair
(kbp) between the two alleles (Fig. 3A and 3B).
Compared with wild-type pigs, genomic sequence
analysis of the od/od genotype revealed that the last
398 bp of intron 7, the entire exon VIII, and approx-
imately 3.7 kbp of intron 8 were deleted in the mu-
tated allele (Fig. 3A). PCR-based genotyping with
genomic DNA was established according to the
identified intronic sequence. Each set of primers
produced fragments of 1020 bp (GLO7p0 and
nGLOi8p3) and 168 bp (nGLOi7p2 and nGLOi8p3)
for the wild-type allele and a fragment of 543 bp
(GLO7p0 and dGLOi7p1) for the deficient allele (Fig.
3A and 3C). OD/OD pigs exhibited the 1020-bp and
168-bp bands, whereas od/od pigs exhibited the 543-
bp band, and OD/od animals exhibited all three of
these bands, as expected (Fig. 3C). Although the
1020-bp band was not always amplified efficiently,
the presence of the 168-bp and the 543-bp bands al-
lowed diagnosis of the genotypes of animals cor-
rectly. The 3¢ breakpoint of the deleted fragment is
in the middle of a 220-bp Sus scrofa DNA SINE se-
quence (accession number X64127).
We analyzed five different pig populations from
Switzerland [Large White (n = 34), Landrace (n = 32),
Hampshire (n = 24), Duroc (n = 25), and Pte´train (n =
22)] and two populations from Denmark in which
Table 2. Partial sequences of the exon/intron boundaries in the porcine GULO gene. The partial sequences of the 5¢- and 3¢-
end of the 12 exons (noted I to XII) and the 11 introns are indicated. The size of each exon (by sequencing) and each intron
(by aPCR or by bSequencing) is given. ukn., unknown.
Exon (size) 3¢ end of exon Intron (size) 5¢ end of exon
I (ukn.) ...TGGAGCCATG gtaggaccac...1200 bpa...cctattccag GTCCATGGGC...
II (102 bp) ...GATCAGAGAG gtgagtgtgc......ukn.....gccttggcag GTGCTGGCGC...
III (126 bp) ...CGTCCTCAAG gtacccggag...1400 bpa...tctcttgcag GTGGACATGG...
IV (95 bp) ...CCTTGTCCAA gtaagagcca...2400 bpa...ccacgcccag CCTGGGAGCT...
V (91 bp) ...GGCCACGCAG gtgagtccac...2300 bpa...ccgctgccag GTGGTGGAGC...
VI (186 bp) ...CTTGAAAGAG gtactgtctt.......ukn.....ccgaggacag GTTCTGGACA...
VII (108 bp) ...CACCAACAAG gtagctgggg.....837 bpb...tgcttcccag CCTCCCTCCT...
VIII (77 bp) ...TCTGGATCAG gtaggaatgc...6700 bpa...tgcccagtag CACCTTCGTG...
IX (150 bp) ...CCATCCCCAG gtaggggttg....820 bpa...ccgagtgcag AGAGAAGACC...
X (165 bp) ...TCATGTACAG gtgacattct....650 bpa...ccctccccag GCCCTACGGC...
XI (91 bp) ...TCATGTACAG gtgacattct...1050 bpa...ccctccccag GCCCTACGGC...
XII ukn. ...TTTGAAATCT
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the original mutations have been detected [Danish
Landrace (n = 100) and Yorkshire (n = 100)], in order
to determine the frequency of the od allele. How-
ever, we did not identify any animals with the mu-
tated allele in these strains.
Expression of the mutated GULO allele is
reduced in heterozygous and vitamin C-deficient
pigs. In order to characterize GULO mRNA ex-
pression, Northern blot analysis was performed on
liver RNA samples from OD/OD, OD/od, and od/od
pigs. Hybridization with a 32P-labeled GULO cDNA
probe showed a 2.2-kbp band (Fig. 4A). Although od/
od pigs expressed less GULO mRNA than wild-type
and heterozygous animals, there are considerable
differences in expression levels within the genotypes
(Fig. 4A, lanes 2 and 3, and lanes 4 and 5, respec-
tively). As GULO is expressed at only moderate
levels, we developed a ribonuclease protection assay
to confirm the results obtained by Northern blot
analysis and to characterize the expression of the od
and OD alleles in more detail. Ribonuclease pro-
tection assays using a 32P-labeled, 399-bp antisense
riboprobe spanning from exon VI to IX identified a
single protected band of 333 bp in OD/OD RNA.
Two bands of 163 bp and 93 bp were protected in
RNA derived from od/od pigs, as expected. All three
bands were found in heterozygous OD/od pigs (Fig.
4B). Quantitative measurement of the intensities of
the protected bands confirmed the results obtained
Fig. 2. Deletion of exon VIII in GULO mRNA of vitamin C-deficient pigs. A. RT-PCR analysis of GULO transcripts. Total
RNA was isolated from liver of wild-type (OD/OD), heterozygous (OD/od), and vitamin C-deficient (od/od) pigs and
subjected to reverse transcription by using the dT17VX primer. The resulting 276-bp and 199-bp fragments represent the
wild-type OD and the deficient od allele, respectively, when GLO6p0, GLO9p1 primers, and the RT products were used as
templates. Sequence analysis of the fragments revealed that the 77-bp deletion in the od allele corresponds to nt 712–788
from exon VIII. B. Schematic representation of the cDNA structure from exon VI to exon IX for wild-type and deficient
alleles. Positions of PCR primers used for RT-PCR are indicated by arrows. Boxes represent exons. C. Partial cDNA
sequence analysis of RT-PCR products. A segment with exons VII–IX of the OD allele depicts nucleotides for wild-type
and mutant cDNA sequences. Amino acids are given as single-letter codes (in bold). Exon sequence deleted in the od allele
is indicated by stippled lines. The 236 amino acids of the N-terminal are identical between wild-type and mutated GULO
protein.
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by Northern blot analysis. The od allele was ex-
pressed at significantly lower levels (187.09 ± 79.81
arbitrary units) than the OD allele (555.34 ± 65.16
arbitrary units; P < 0.01; n = 16). The RT-PCR results
of the heterozygous pigs supported these findings,
because the signal intensity of the od allele was
always lower than that of the OD allele (Fig. 2A,
OD/od pig).
Discussion
Vitamin C-deficient pigs suffer from GULO defi-
ciency, as liver microsomes from these animals are
unable to synthesize L-AA in vitro from L-gulono-
lactone substrate. GULO enzyme activity and plas-
ma vitamin C levels in pigs that carry one normal
allele and one od allele (OD/od) are different from
those of wild-type animals when the pigs were fed a
diet lacking vitamin C for one week. However, only
plasma vitamin C differences were statistically sig-
nificant.
We have mapped the OD locus in pigs and the
porcine GULO to SSC14q14 (Hasan et al. 1999).
Therefore, GULO was proposed as a promising
functional and positional candidate for vitamin C
deficiency in pigs. We further characterized the
GULO gene in order to identify the specific molec-
ular defect in od/od pigs. There is strong evidence
that a 4.2-kbp intragenic deletion within the GULO
gene that includes exon VIII and parts of the sur-
rounding introns leads to a frame shift and a pre-
mature termination codon that is responsible for the
vitamin C-deficient phenotype.
If the od allele is translated at all, the frameshift
deletion would lead to a truncated protein of 356
amino acids, where the last 120 amino acids are al-
tered. Insertions or deletions not divisible by 3 will
create, on average, a new stop codon (TAG, TAA, or
TGA) within 20 downstream codons (Byers 2002). In
this respect, the mutated GULO protein carries an
exceptionally long, altered C-terminus.
The presence of a transmembrane domain in the
GULO protein is controversial. Nishikimi et al.
(1994) predicted five transmembrane domains in the
rat GULO protein. The first three of these should be
preserved in the truncated protein of the pig. How-
Fig. 3. Intragenic deletion in the GULO gene in vitamin C-deficient pigs. A. Schematic representation of the genomic
structure from exon VII to exon IX for normal (OD) and deficient (od) alleles. The last 398 bp of intron 7, the complete
exon VIII (77 bp), and the first 3.7 kbp of intron 8 are deleted in the mutated allele, as indicated by stippled lines. Exons are
indicated by open boxes, and intron sequences are represented by closed boxes. Positions of primers used for long-range
PCR and PCR-based genotyping are indicated by arrows. B. Long-range PCR analysis. GLO7p0 and GLO9p1 primers and
genomic DNA of wild-type (OD/OD) and deficient (od/od) pigs resulted in a 7.6-kbp and a 3.4-kbp fragment, respectively.
Both fragments are generated in heterozygous (OD/od) animals. The difference of the intensities of the od bands between
od/od and OD/od animals may be explained by the number of alleles and the more efficient amplification of the small
fragment in the PCR. Sequence analysis of the fragments revealed that exon VIII is part of the 4.2-kbp deletion. C. Practical
PCR diagnostic test. GLO7p0, nGLOi7p2, nGLOi8p3, and dGLOi7p1 primers and genomic DNA were used as templates
to amplify 1020-bp and 168-bp fragments in the wild-type and a 543-bp fragment in the deficient pig. All three bands are
generated in heterozygous animals. The 4.7-kbp GLO7p0-dGLOi7p1 fragment was not amplified in the wild-type and
heterozygous pigs under the PCR conditions described in the Materials and methods section.
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ever, when the amino acid sequences of mouse (ac-
cession number P58710) and rat GULO proteins
(accession number P10867) were analyzed with the
TMHMM software program (Mo¨ller et al. 2001), only
a single transmembrane domain was predicted be-
tween amino acid positions 250 and 272. When the
mutant porcine GULO protein was analyzed, no
transmembrane domains were predicted. If the
mutated GULO enzyme is not a membrane-bound
protein, then no activity may be expected in the
solubilized microsomes. In order to determine
whether the mutated GULO protein is present in
other fractions, we measured GULO activity and
performed Western blot analysis (data not shown).
As expected, GULO activity of OD/OD and OD/od
was found only in the cleared homogenate and the
solubilized microsomes. However, no GULO activ-
ity was detected in any of the fractions of the od/od
pigs. These results suggested that activity of mutant
GULO is below the level of detection, independent
of its localization. Western blot analysis was per-
formed with an anti-rat GULO polyclonal antibody.
However, the results were inconclusive, owing to
high background and presumably to the insufficient
affinity between the anti-rat antibody and the por-
cine GULO proteins.
The lack of a transmembrane domain in the
truncated GULO protein may dramatically alter the
conformation of the putative peptide. This change
may affect the ability of the enzyme to access its
substrate (L-gulonolactone) or the conformation of the
catalytic site itself. However, our cDNA sequencing
data suggest that the binding of the FAD group to the
H53 residue contained in the consensus sequence of
P-(x)10-E-I-(x)3-L-(x)9-V-(x)3-G-G-G-H (August et al.
1994; Brandsch et al. 1987; Dittrich and Kutchan
1991; amino acid positions 20–53) should not be af-
fected in the mutant GULO.
The od allele is expressed much less in hetero-
zygous and vitamin C-deficient animals than the
OD allele in heterozygous and wild-type animals.
This is most probably owing to nonsense-mediated
decay, an RNA surveillance pathway that detects
and destroys aberrant mRNAs containing premature
termination codons (Hentze and Kulozik 1999; Li
and Wilkinson 1998; Maquat 2002).
Our procedure for measurement of GULO ac-
tivity is comparable to the recently published pro-
cedure of Ching et al. (2003), who showed that
10 mM of L-gulonolactone substrate and a 1:4 tissue
sample-to-buffer ratio (weight:volume) is optimal
regarding the amount of interfering substances.
However, their GULO activities are not directly
comparable to our results, as we investigated older
animals, and we related the GULO activities to the
microsomal protein fraction instead of to total liver
homogenate.
So far, not much is known about the regulation
of GULO activity. We found reduced GULO activi-
ties (50%) in the liver of sexually mature pigs when
we fed 50 mg L-AA/kg BW for 4 weeks (data not
shown). However, the expression of GULO mRNA
Fig. 4. Expression of the GULO gene in liver of wild-type
(OD/OD), heterozygous (OD/od) and deficient (od/od)
pigs. A. Northern blot analysis hybridization with a labe-
led porcine PCR probe including exons IX and X of the
GULO gene. The lower panel provides loading controls
following hybridization with a porcine b-actin PCR probe.
Lane 1, spleen of OD/OD pigs (negative control). Lanes 2
and 3, liver of OD/OD. Lanes 4 and 5, liver of OD/od pigs.
Lanes 6 and 7, liver of od/od pigs. The full-length mRNA
transcripts of GULO were estimated to be 2.2 kbp. The
hybridization signals are weak in od/od pigs, while OD/
OD and OD/od pigs show an equally strong hybridization
signal. B. Ribonuclease protection assay using liver RNA
and GULO antisense and 18S antisense riboprobes. Lanes
1 and 4, run-off GULO antisense transcripts (399 bp, in-
cluding 66 bp of vector sequence). Lane 3, run-off 18S
antisense transcripts (109 bp). Lane 2, unprotected probes
treated with RNases A and T1 (digestion controls). Lane 5,
protected bands of 333 bp of a wild-type pig. Lanes 6 to 8,
protected bands of 163 bp and 93 bp of od/od pigs. Lanes 9
to 11, all three protected bands of heterozygous pigs. For
the statistical analysis, eight pigs each were investigated.
Here, a representative ribonuclease protection assay is
shown.
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was not affected by dietary L-AA intake in wild-type,
heterozygous, and deficient pigs. Although L-AA is
known to regulate the expression of many genes
(reviewed by Hitomi and Tsukagoshi 1996) and al-
though there were large individual differences in
GULO mRNA expression, GULO activity seems not
to be regulated at the level of transcription. A direct
inhibition of GULO by L-AA is unlikely, since the
addition of super physiologic amounts of L-AA to
liver homogenates did not alter the rate of L-AA
formation in vitro (data not shown). This is in
agreement with previous observations with either
glucuronolactone (a precursor of gulonolactone) or
gulonolactone as substrate (Tsao and Young 1989,
1990). Tsao and Young (1989) also found a negative
correlation between GULO activity and L-AA con-
tent in the hepatic portal blood of mice. The control
mechanism for the conversion of gulonolactone to L-
AA is stereospecific because large amounts of dietary
erythorbic acid, a stereo isomer of AA, could not
reduce the rate of L-AA formation when gulonolac-
tone was used as substrate (Tsao and Young 1990).
Furthermore, Tsao and Young (1989) suggested that
the feedback control mechanism for the enzymatic
conversion of glucuronolactone to gulonolactone
was not stereospecific.
In all vitamin C deficiency syndromes described
to date, the GULO gene is affected. The human non-
functional GULO pseudogene (GULOP) exhibits
deletions in exons VIII and XI as well as a large
number of random mutations throughout the gene
(Nishikimi et al. 1994). The sequences homologous
to exon I and exon V of the rat GULO gene and the
sequence corresponding to a 3¢-region of rat exon VI
are absent in the guinea pig gene homolog. As in
humans, these mutations impair the expression of
GULO mRNA in guinea pigs (Nishikimi et al. 1992).
In the osteogenic disorder Shionogi (ODS) rat, an A-
to-G transition leads to a 61Cysﬁ61Tyr substitu-
tion, which is responsible for the dramatic decrease
in GULO enzyme activity (Kawai et al. 1992).
However, this mutation did not affect the amount of
mRNA produced when allele-specific expression
was characterized in transfected COS-1 cells (Kawai
et al. 1992). More recently, Maeda et al. (2000) gen-
erated a vitamin C-deficient (Gulo )/)) mouse strain
by deleting exons III and IV through homologous
recombination.
The availability of a strain of pigs unable to
synthesize L-AA has made it possible to evaluate the
role of vitamin C in an animal species that, bio-
chemically and physiologically, more closely re-
sembles humans than guinea pigs or other rodents.
Since vitamin C intake can be controlled by diet,
this pig model is particularly valuable for investi-
gating the interplay between endogenous and exo-
genous redox systems, genetic factors, and the
protective role of vitamin C against the development
of various degenerative diseases, including cardio-
vascular disease and cancer, which are the major
causes of death in industrialized countries (Head
1998; Lynch et al. 1996).
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